The Role of 18F-FDG PET/CT in the Evaluation of Peritoneal Thickening of Undetermined Origin

Medicine (United States)

Volumn 95, Issue 15, 2016, Pages

  Chen, Ruohua ^a   Chen, Yumei ^a   Liu, Liu ^a   Zhou, Xiang ^a   Liu, Jianjun ^a   Huang, Gang ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI UNIVERSITY OF MEDICINE AND HEALTH SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ACCURACY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASCITES; BACTERIAL PERITONITIS; CLINICAL FEATURE; COLON CARCINOMA; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LIVER CANCER; LIVER CIRRHOSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT PERITONEAL THICKENING; NEPHRITIS; OVARY ADENOCARCINOMA; PERITONEAL DISEASE; PERITONEAL THICKENING; PET-CT SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SMALL INTESTINE CARCINOMA; TUBERCULOUS PERITONITIS; WHOLE BODY CT; WHOLE BODY PET; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; MULTIMODAL IMAGING; PATHOLOGY; PERITONEAL DISEASES; PERITONITIS, TUBERCULOUS; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; X-RAY COMPUTED TOMOGRAPHY;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; PERITONEAL DISEASES; PERITONITIS, TUBERCULOUS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84964608658     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003023     Document Type: Article

References (22)

1. Chu DZ, Lang NP, Thompson C, et al. Peritoneal carcinomatosis in nongynecologic malignancy: a prospective study of prognostic factors. Cancer. 1989;63:364-367.
2. O'Neill AC, Shinagare AB, Rosenthal MH, et al. Differences in CT features of peritoneal carcinomatosis, sarcomatosis, and lymphoma-tosis: retrospective analysis of 122 cases at a tertiary cancer institution. Clin Radiol. 2014;69:1219-1227.
3. Karaosmanoglu D, Karcaaltincaba M, Oguz B, et al. CT findings of lymphoma with peritoneal, omental and mesenteric involvement: peritoneal lymphomatosis. Eur J Radiol. 2009;71:313-317.
4. Muroni M, Rouet A, Brocheriou I, et al. Abdominal tuberculosis: utility of laparoscopy in the correct diagnosis. J Gastrointest Surg. 2015;19:981-983.
5. Reading CC. Percutaneous needle biopsy. Abdom Imaging. 1997;22:311-312.
6. Boudiaf M, Bedda S, Soyer P, et al. Preoperative evaluation of gastric adenocarcinomas: comparison of CT results with surgical and patholgic results. Ann Chir. 1999;53:115-122.
7. Low RN, Barone RM, Lacey C, et al. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. Radiology. 1997;204:513-520.
8. Kunikowska J, Matyskiel R, Toutounchi S, et al. What parameters from 18F-FDG PET/CT are useful in evaluation of adrenal lesions? Eur J Nucl Med Mol Imaging. 2014;41:2273-2280.
9. van den Esschert JW, Bieze M, Beuers UH, et al. Differentiation of hepatocellular adenoma and focal nodular hyperplasia using 18F-fluo-rocholine PET/CT. Eur J Nucl Med Mol Imaging. 2011;38:436-440.
10. Rahbar K, Seifarth H, Schafers M, et al. Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT. J Nucl Med. 2012;53:856-863.
11. Chen YK, Su CT, Chi KH, et al. Utility of 18F-FDG PET/CT uptake patterns in Waldeyer's ring for differentiating benign from malignant lesions in lateral pharyngeal recess of nasopharynx. J Nucl Med. 2007;48:8-14.
12. Tessonnier L, Sebag F, Palazzo FF, et al. Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours? Eur J Nucl Med Mol Imaging. 2008;35:2018-2025.
13. Koc S, Beydilli G, Tulunay G, et al. Peritoneal tuberculosis mimicking advanced ovarian cancer: a retrospective review of 22 cases. Gynecol Oncol. 2006;103:565-569.
14. Delgado-Bolton RC, Fernandez-Perez C, Gonzalez-Mate A, et al. Meta-analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors. J Nucl Med. 2003;44:1301-1314.
15. Kwee TC, Basu S, Cheng G, et al. FDG PET/CT in carcinoma of unknown primary. Eur J Nucl Med Mol Imaging. 2010;37:635-644.
16. Suzuki A, Kawano T, Takahashi N, et al. Value of 18F-FDG PET in the detection of peritoneal carcinomatosis. Eur J Nucl Med Mol Imaging. 2004;31:1413-1420.
17. Klumpp BD, Schwenzer N, Aschoff P, et al. Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI. Abdom Imaging. 2013;38:64-71.
18. van Waarde A, Cobben DC, Suurmeijer AJ, et al. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model. J Nucl Med. 2004;45:695-700.
19. Zhang M, Jiang X, Zhang M, et al. The Role of 18F-FDG PET/CT in the evaluation of ascites of undetermined origin. J Nucl Med. 2009;50:506-512.
20. Ulusoy AN, Karabicak I, Dicle K, et al. Peritoneal tuberculosis in premenopausal patients with elevated serum CA 125. Arch Gynecol Obstet. 2010;282:639-642.
21. Sharma P, Marangmei C. Tubercular meningitis on 18F-FDG PET/CT: incidentally detected and masquerading as relapse in a patient with ovarian burkitt lymphoma. Clin Nucl Med. 2015.
22. Lataifeh I, Matalka I, Hayajneh W, et al. Disseminated peritoneal tuberculosis mimicking advanced ovarian cancer. J Obstet Gynaecol. 2014;34:268-271.